S&P 500
5,970.37
+0.6%
+$34.43
DJI
42,519.64
+0.5%
+$214.16
NASDAQ
19,398.96
+0.8%
+$156.34
Bitcoin
105,784.00
+0.9%
+896.37
AAPL
$203.38
+0.8%
+$1.68
AMZN
$205.89
-0.4%
-$0.76
GOOG
$167.85
-1.5%
-$2.52
META
$667.31
-0.5%
-$3.59
MSFT
$463.24
+0.3%
+$1.28
NVDA
$141.38
+2.9%
+$4.00
TSLA
$344.95
+0.7%
+$2.26
Fresh2 Group (NASDAQ: ANPC)
Some price data may be temporarily unavailable.
Fresh2 Group Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
Fresh2 Group Company Info
Anpac Bio-Medical Science Co., Ltd., is a biotechnology company. It engages in marketing and selling multi-cancer screening and detection test that uses patented cancer differentiation analysis, or CDA, technology and proprietary cancer-detection device or CDA device. The company was founded by Chris Chang Yu and He Yu in 2010 and is headquartered in Lishui, China.
News & Analysis
No articles found.
Valuation
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.